OBJECTIVES Clinical trial evidence indicates that atherosclerosis is considered one of the major risk factors for the chronic kidney diseases (CKD) and the blockade of renin-angiotensin system (RAS) has been shown to delay the progression of CKD to end-stage renal diseases and reduce renal events in patients. Angiotensin-converting enzyme 2 (ACE2) is known as a negative regulator of the RAS, but its role in atherosclerotic renal injury are poorly understood. We hypothesized that ACE2 would exert beneficial effects on renal injury in apolipoprotein E (ApoE)-knockout (KO) mice.
RESULTS Compared to WT control mice, plasma total cholesterol (CHO) and triacylglycerol (TG) concentrations were elevated in both the ApoEKO mice and ACE2/ApoE double-KO mice (P<0.05, respectively). ACE2 deficiency was linked with increased circulating Ang II levels and a modest elevation in SBP levels in both the ACE2KO and ACE2/ApoE double-KO mice. Compared with the ApoEKO kidneys, the level of pro-inflammatory cytokines/chemokines and adhesion molecules were increased in the ACE2/ApoE double-KO kidneys, including interleukin (IL)-1beta, IL-6, tumor necrosis factor-alpha (TNF-alpha), TNFRSF1A, RANTES, and intercellular adhesion molecule 1. Renal dysfunction and ultrastructure injury were aggravated in the ApoE/ ACE2 double-KO mice associated with increases of plasma creatinine and blood urea nitrogen levels (P<0.01, respectively). However, ACE2 deficiency had no effect on renal TNFRSF1B expression and circulating lipid levels in the ACE2/ApoE double-KO mice (P>0.05, respectively).
CONCLUSIONS Loss of ACE2 exacerbates kidney inflammation and adverse renal injury in the ApoE-deficient mice via activation of the TNFalpha/TNFRSF1A signaling pathway. These observations indicate detrimental effect of ACE2 deficiency on inflammation and renal dysfunction and point to ACE2 as a novel target for kidney-protective therapies. Strategies aimed at enhancing ACE2 action may have important therapeutic potential for atherosclerotic renal injury and CKD. This work was supported by Training Program of the National Major Research Plan (91339108), the National Basic Research Program of China (2014CB542300), and the National Natural Science Foundation of China (81370362 & 81170246) . OBJECTIVES To determine whether triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C), which has been shown to be an indicator of the metabolic syndrome (MetS) and insulin resistance (IR), can predict cardiovascular risk factors in the Chinese Han population in Xinjiang.
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METHODS The Cardiovascular Risk Survey (CRS) was conducted from
October 2007 to March 2010. A total of 14618 representative participants were selected using a four-stage stratified sampling method. A total of 5757 Han participants were included in the study. The present statistical analysis was restricted to the 5595 Han subjects who had complete anthropometric data. The sensitivity, specificity, and distance on the receiver operating characteristic (ROC) curve in each TG/HDL level were calculated. The shortest distance in the ROC curves was used to determine the optimal cutoff of the TG/HDL-C ratio for detecting cardiovascular risk factors.
RESULTS
The prevalence of hypertension, hypercholesterolemia and hypertriglyceridemia were higher with higher TG/HDL-C ratio for both men and women. The TG/HDL-C ratio was positively associated with systolic blood pressure, diastolic blood pressure and serum concentrations of total cholesterol. The optimal TG/HDL-C ratio cutoffs for predicting hypertension, dyslipidemia, diabetes and ! two of these risk factors for Han adults in Xinjiang were 1.3, 1.3, 1.4, 1.4 in men and 0.9, 1.0, 1.0, 1.1 in women, respectively.
CONCLUSIONS The evaluation of TG/HDL-C ratio should be considered for one of cardiovascular risk factor predictors among Han adults in Xinjiang.
GW26-e2293 Renal Sympathetic Nerve Modulates Ventricular Electrophysiological Characteristics
Bing Huang, 1,2 Lilei Yu, 1,2 Xiaoya Zhou, 1,2 Songyun Wang, 1,2 Zhuo Wang, 1,2 Liping Zhou, 1,2 Zhibing Lu, 1,2 Bo He, 1,2 Hong Jiang 1,2 1 Department of Cardiology, Renmin Hospital of Wuhan University; 2 Cardiovascular Research Institute of Wuhan University, Wuhan, China OBJECTIVES Recently, renal sympathetic nerve (RSN) has become a hot target for therapeutic intervention in several cardiovascular diseases, including ventricular arrhythmias. However, the role of RSN in the modulation of ventricular electrophysiological characteristics is still poorly understood. The present study aimed to evaluate the effect of RSN activation (RSN-A) or denervation (RSN-D) on ventricular electrophysiology.
METHODS Twenty-one dogs were randomly assigned into RSN-A group (n¼8), RSN-D group (n¼8) and control group (n¼5). Animals in RSN-A group received 3 hours of high frequency stimulation (20 Hz, 2 ms duration) at the voltage required to increase the systolic blood pressure by 10% to simulate a hyperactive state of RSN. RSN-D was achieved by ablating bilateral renal nerves. High frequency stimulation (20 Hz, 2 ms duration, 15 mA, 60s) was applied before and after each ablation to confirm the adequacy of denervation. Ventricular electrophysiological characteristics were measured at baseline and after interventions in each group. CONCLUSIONS RSN-A and RSN-D cause different effects on ventricular electrophysiological characteristics. These results suggest that RSN may play an important role in the modulation of ventricular electrophysiology and arrhythmogenesis. tissue engineering as biologic scaffold in recent years. Before achieving the ultimate goal of engineering a functional heart, however, some challenges regarding the scaffold preparation and the sources of seeding cells still need to be addressed. The purpose of this study was to establish and optimized the methodology of decellularized heart scaffold. It's also expected to establish a platform for the decellularied heart tissue-based scaffold evaluation in vitro.
RESULTS
METHODS The decellularized heart scaffold was prepared by coronary perfusion. Histological staining, DNA content assay and scanning electron microscopy (SEM) were performed to evaluate the decellularized heart scaffold. Neonatal rat cardiac cells and rat bone marrow multipotent stromal cells (rBMSCs), which have the potential to transdifferentiate into cardiomyocytes, were adopted to serve as seed cells respectively to construct a tissue-engineered 3D cardiac model. To improve the viability of cells on 3D scaffold, rotary cell culture system (RCCS) was also applied to enhance the mass transport during the cultivation in vitro. The tissueengineered 3D model was evaluated by histological staining, SEM as well as quantitative real-time RT-PCR analysis.
RESULTS Both histological staining and SEM detection revealed that decelluarized heart scaffold preserves the ultrastructural conformation of the heart with few nuclei. The DNA content of the scaffold was 1.64AE0.03ng/mg, which is significantly lower than that of the control group (native heart tissue). Histological staining and SEM images showed their good viability during the 3D culture. Majority of the seeded neonatal rat cardiac cells or rBMSCs grow on the surface of the scaffold under the static culture condition. By contrast, a number of cells distributing within the scaffolds were observed in the dynamic cultures, indicating its good mass transport and microenvironment for cell growth. Quantitative real-time RT-PCR analysis revealed that expression level of transcript factor Gata 4 in the induced rBMSCs was improved significantly when compared to the negative control. Similarly, the expression of gene Gata4 in the rBMSCs inoculated into the decelluarized heart scaffold is much higher than that of the negative control and the induced group (5-azacytidine-treated).
CONCLUSIONS The decellularized heart scaffolds prepared in the present study were decellularized completely and preserved the full extracellular matrix. It possesses not only good biocompatibility but also naturally occurring three-dimensional structure. Moreover, our research indicates that the decellularized heart scaffold might potentially induce the differentiation of rBMSCs into cardiomyocytes. Combined with the RCCS cultivation, the tissue-engineered 3D cardiac model based on decellularized heart scaffold can better simulate the microenvironment in vivo and might potentially be utilized for cardiac tissue engineering.
GW26-e2370 Red Cell Distribution Width and Risk of Long-Term All-Cause Mortality and Cardiovascular Events Among Patients With Acute Coronary Syndrome: A Meta-Analysis of Observational Studies
Yun Zhou, Dongze Li, Yining Yang, Yitong Ma Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University OBJECTIVES Red cell distribution width (RDW) might be a novel biomarker that reflects multiple physiological impairments related to atherosclerosis and acute coronary syndrome (ACS). We conducted this systematic review and meta-analysis to evaluate the association of RDW between risk of major adverse cardiovascular Events (MACEs), all-cause and cardiovascular mortality in ACS patients.
METHODS Relevant studies were searched and identified in the Cochrane Library, PubMed and Embase databases. English-language studies that reported risk estimates for RDW and MACEs, all-cause and cardiovascular mortality were included. Data were extracted regarding the characteristics and clinical outcomes, and a quality assessment was conducted. Results were extracted for the average RDW level, and meta-analyses were carried out using random effects models.
RESULTS
We collected 14 articles. 9 investigated the association between RDW and all-cause mortality, 3 evaluated the association between RDW and risk of cardiovascular mortality, and 7 reported the association between RDW and risk of MACEs. We found that RDW was associated with a significantly increased risk of all-cause mortality (HR:3.372; 95%CI:2.014 -5.645; P <0.001), cardiovascular mortality (HR: 2.342; 95%CI: 1.769 -3.100; P <0.001) and MACEs (HR: 2.120; 95% CI: 1.515-2.965; P <0.001;).
CONCLUSIONS The meta-analysis indicates that RDW significantly increased the risk of MACEs, all-cause and cardiovascular mortality in ACS patients.
GW26-e5367 SIRT3 Deficiency Induces Endothelial Insulin Resistance and Vascular Dysfunction in Obese Mice and Human Subjects
Lu Yang, 1,2 Gao Feng 1 1 Department of aerospace medicine, Fourth Military Medical University; 2 Department of Cardiology, Fourth Military Medical University OBJECTIVES Recent evidence implicates SIRT3 as a central regulator of mitochondrial redox balance and metabolic homeostasis but the contribution of SIRT3 to vascular function remains unknown. The aim of this study was to investigate the role of SIRT3 in obesity-induced endothelial insulin resistance and subsequent vascular dysfunction.
METHODS Both vascular response to insulin and SIRT3 expression were detected in morbid obese human subjects undergoing bariatric surgery and non-obese controls. Male SIRT3 knockout mice and wide type littermates were fed with a standard chow diet or a high fat diet (HFD) for 24 weeks.
RESULTS
We found an impaired insulin-induced mesenteric vasorelaxation (82.46AE8.5% vs. 54.93AE6.46%, n¼8-12, P<0.05) and concomitant a 50% reduced vascular SIRT3 expression in morbid obese human subjects compared with non-obese controls. Downregulation of SIRT3 either by siRNA or by palmitate excess treatment in cultured human endothelial cells resulted in overproduction of mitochondrial reactive oxygen species (mtROS) and impaired insulin signaling as indicated by decreased phosphorylation of Akt and eNOS and subsequent reduced NO release. Additionally, obese mice induced by 24-week HFD displayed an impaired endothelium-dependent vasorelaxation to both insulin (40.68 AE 3.68% vs. 64.98 AE 2.85%, n ¼ 8, P < 0.01) and acetylcholine (46.45 AE 4.93% vs. 100.59 AE 2.35%, n ¼ 6, P < 0.01), which was further exacerbated by gene deletion of SIRT3 (P < 0.05). Moreover, lentivirus-mediated restoration of vascular SIRT3 rescued HFD-induced endothelial dysfunction in SIRT3 knockout mice (46.84 AE 3.29% vs. 29.56 AE 2.99%, n ¼ 6, P < 0.01 for response to insulin; 75.59 AE 4.93% vs. 57.25 AE 3.81%, n ¼ 6, P < 0.01 for response to acetylcholine). Elimination of mtROS with MitoTEMPO not only restored insulin-stimulated NO production in SIRT3 knockdown cells but also improved insulininduced vasorelaxation in SIRT3 knockout mice fed with HFD.
CONCLUSIONS Our findings suggest that SIRT3 positively regulates endothelial insulin sensitivity and show that SIRT3 deficiency and resultant mtROS overproduction contribute to vascular dysfunction in obesity. OBJECTIVES Diabetes mellitus (DM) is one of the greatest public health threats in modern societies. And among all the diabetic complications, diabetic cardiomyopathy (DCM) has been recognized as the leading cause of morbidity and mortality. Thus, the elucidation of pathological mechanisms in DCM is urgently needed, so as to develop novel therapies. Fenofibrate (FF) is a peroxisome proliferator-activated receptor-a (PPARa) agonist. It has long been used clinically to lower lipid levels for about three decades. Here we tested whether FF can be repurposed to prevent diabetic cardiomyopathy (DCM) for type 1 diabetes, and delineated the mechanism of its action.
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METHODS Streptozotocin (STZ) was used to induce type 1 diabetes in wild type C57BL/6J mice and fibroblast growth factor 21 knock-out (FGF21KO) mice, diabetic and age-matched control mice were then treated with vehicle or FF by gavage every other day for 3 or 6 months. After that we sacrificed the animal models and obtained heart tissue for further study including western blot assay, real-time PCR, pathology staining and so on. The H9c2 cardiac myoblast cells were used for the in vitro study.
RESULTS FF prevented diabetes-induced cardiac dysfunction as well as cardiac inflammation, oxidative stress and remodeling (PAI-1, TNFa, 3NT, 4HNE, CTGF, TGFb), along with up-regulated cardiac expression of FGF21 and sirtuin1 (Sirt1). In contrast to wild-type diabetic mice, FGF21-KO mice showed worse biochemical, pathological, and functional changes of the heart following diabetes induction, and failed to respond to FF treatment even though FF similarly lowered systemic lipid profile in both WT and FGF21-KO diabetic mice. 
